Gastroenteritis norovirus
(UMLS:C2242683)
- UMLS ID:
- C2242683
- MeSH ID:
- N/A
Synonym(s)
1.
Gastroenteritis norovirus
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Dimethyl Fumarate | FAERS: 13 | US FAERS | |
| 2 | Ruxolitinib phosphate | FAERS: 7 | US FAERS | |
| 3 | Clozapine | FAERS: 6 | US FAERS | |
| 4 | Prednisolone | FAERS: 4 | US FAERS | |
| 5 | Lenalidomide | FAERS: 3 | US FAERS | |
| 6 | Mycophenolic Acid | FAERS: 3 | OFFSIDES US FAERS | |
| 7 | Sirolimus | FAERS: 3 | US FAERS | |
| 8 | Sunitinib | FAERS: 3 | US FAERS | |
| 9 | Teriparatide | FAERS: 3 | US FAERS | |
| 10 | pirfenidone | FAERS: 3 | US FAERS | |
| 11 | 4-Aminopyridine | FAERS: 2 | US FAERS | |
| 12 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | Deferasirox | FAERS: 2 | OFFSIDES US FAERS | |
| 14 | Epoprostenol | FAERS: 2 | US FAERS | |
| 15 | Glatiramer Acetate | FAERS: 2 | US FAERS | |
| 16 | Insulin Glargine | FAERS: 2 | US FAERS | |
| 17 | Rivastigmine | FAERS: 2 | US FAERS | |
| 18 | Tacrolimus | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 19 | Varenicline | FAERS: 2 | US FAERS | |
| 20 | apremilast | FAERS: 2 | US FAERS | |
| 21 | tofacitinib | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 22 | 5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine | FAERS: 1 | US FAERS | |
| 23 | Abiraterone Acetate | FAERS: 1 | US FAERS | |
| 24 | Aspirin-oxycodone hydrochloride-oxycodone terephthalate combination | FAERS: 1 | US FAERS | |
| 25 | Axitinib | FAERS: 1 | US FAERS | |
| 26 | Bortezomib | FAERS: 1 | US FAERS | |
| 27 | Bosentan | FAERS: 1 | US FAERS | |
| 28 | Canagliflozin | FAERS: 1 | US FAERS | |
| 29 | Capecitabine | FAERS: 1 | OFFSIDES US FAERS | |
| 30 | Clopidogrel | FAERS: 1 | US FAERS | |
| 31 | Cysteamine | FAERS: 1 | US FAERS | |
| 32 | Dasatinib | FAERS: 1 | US FAERS | |
| 33 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 34 | LCZ 696 | FAERS: 1 | US FAERS | |
| 35 | Lapatinib | FAERS: 1 | OFFSIDES US FAERS | |
| 36 | Methotrexate | FAERS: 1 | US FAERS | |
| 37 | Methylphenidate | FAERS: 1 | US FAERS | |
| 38 | N-carbamylglutamate | FAERS: 1 | US FAERS | |
| 39 | Naltrexone | FAERS: 1 | US FAERS | |
| 40 | Oseltamivir | FAERS: 1 | US FAERS | |
| 41 | Oxymorphone | FAERS: 1 | US FAERS | |
| 42 | Thalidomide | FAERS: 1 | US FAERS | |
| 43 | Tiotropium Bromide | FAERS: 1 | US FAERS | |
| 44 | Triumeq | FAERS: 1 | US FAERS | |
| 45 | Valproic Acid | FAERS: 1 | US FAERS | |
| 46 | Voriconazole | FAERS: 1 | US FAERS | |
| 47 | Warfarin | FAERS: 1 | US FAERS | |
| 48 | acetaminophen, aspirin, caffeine drug combination | FAERS: 1 | US FAERS | |
| 49 | apixaban | FAERS: 1 | US FAERS | |
| 50 | cabozantinib | FAERS: 1 | US FAERS | |
| 51 | deflazacort | FAERS: 1 | US FAERS | |
| 52 | lanreotide | FAERS: 1 | US FAERS | |
| 53 | lenvatinib | FAERS: 1 | US FAERS | |
| 54 | niraparib | FAERS: 1 | US FAERS | |
| 55 | obeticholic acid | FAERS: 1 | US FAERS | |
| 56 | rotigotine | FAERS: 1 | US FAERS | |
| 57 | ziprasidone | FAERS: 1 | US FAERS | |
| 58 | zolmitriptan | FAERS: 1 | US FAERS | |
| 59 | Ambroxol | OFFSIDES | ||
| 60 | Cefotaxime | OFFSIDES | ||
| 61 | Cytarabine | OFFSIDES | ||
| 62 | Folic Acid | OFFSIDES | ||
| 63 | Mercaptopurine | OFFSIDES | ||
| 64 | Mesna | OFFSIDES | ||
| 65 | Octreotide | OFFSIDES | ||
| 66 | Propafenone | OFFSIDES | ||
| 67 | Zoledronic Acid | OFFSIDES | ||
| 68 | fludarabine phosphate | OFFSIDES | ||
| 69 | fludarabine | OFFSIDES | ||
| 70 | posaconazole | OFFSIDES | ||
| 71 | prothipendyl | OFFSIDES | ||
| 72 | urapidil | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.